Implementation of a new treatment scheme for primary hip prosthesis implantations in the German health care system in collaboration with DRV
- Conditions
- Patient with advanced osteoarthritis and indication for endoprosthetic joint replacement of the hip joint (hip TEP)
- Registration Number
- DRKS00032780
- Lead Sponsor
- Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Indication for primary implantation of a total hip joint endoprosthesis
- age: 18 - 80 years
- Patient is gainfully employed
- ASA 3-6
- BMI > 34 kg/m2
- Diabetes mellitus with blood glucose imbalances (hypoglycemias)
- Chronic renal failure with GFR < 60 (stage III according to NKF)
- Coronary artery disease with Z.n. intervention within the last 2 years or further complaints
- Permanent anticoagulation with heart valve replacement
- Dementia or other neurological diseases with alteration of gait (Parkinson's syndrome, myasthenia gravis, visual pathway disorders, etc.)
- Anemia / hemophilia / thrombophilia with secondary DVT / LAE
- Known depression / psychoaffective disorder
- Chronic pain patient with long-term opioid medication
- Patients with rheumatoid arthritis with expected limitation in postoperative mobilization
- COPD with limitations in daily life/sleep apnea syndrome
- Lack of compliance for complex treatment procedures
- Language barrier
- Excessive demands in the home situation during outpatient follow-up treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method